Back HIV/AIDS

HIV / AIDS

Senate Approves Bill to Allow HIV+ Patients to Receive HIV+ Donor Organs

The U.S. Senate this week unanimously passed the HOPE Act, a bill that will make an exception to current law enabling people with HIV to receive organs for transplantation from another HIV positive individual. The measure now awaits approval from the House of Representatives.

alt

New NRTI BMS-986001 Potently Suppresses HIV in Early Monotherapy Study

BMS-986001, a novel thymidine nucleoside reverse transcriptase inhibitor (NRTI) being developed by Bristol-Myers Squibb, demonstrated good antiviral activity and appeared safe and well-tolerated in a 10-day monotherapy study, researchers reported in the July 1, 2013, Journal of Acquired Immune Deficiency Syndromes.

alt

30 Years of HIV: Long Road Ahead to a Cure

Scientists from around the world met to review the future of HIV scientific research at the Institut Pasteur in Paris, last month -- 30 years after the discovery of HIV by a team based at the institute. The prospects for a cure for HIV infection were a major theme of the meeting, which attracted around 500 scientists, chiefly from France and the United States.

alt

Younger People with HIV Are Missing Out in the Continuum of Care

Young people with HIV are less likely to access and benefit from HIV care and treatment at all levels of the "care cascade" from testing to starting antiretroviral therapy (ART) to achieving viral suppression, according to findings reported in the June 17, 2013, advance edition of JAMA Internal Medicine. Overall, only about 25% of HIV positive people achieved undetectable viral load.

alt

GRACE Survey Sheds Light on Treatment Benefits and Barriers for HIV+ Women

Caring for children, unemployment, and transportation difficulties were among the factors most likely to lead to poor adherence, early dropout, and suboptimal response to antiretroviral therapy (ART) among participants in the GRACE trial, which tested darunavir (Prezista) in a study population consisting largely of women of color. Overall, they said participation was a positive experience and they would encourage others to join a clinical trial.

alt

HIV Treatment Outcomes Improving among Transgender People

Transgender people with HIV are now doing as well on antiretroviral therapy (ART) as other patients and achieving similar outcomes, according to a retrospective analysis published in the May 30, 2013, advance edition of Clinical Infectious Diseases.

alt

Bone Loss and Fracture Risk are 'Modest' among HIV+ People, Linked to Tenofovir, Smoking, and HCV

Continued bone loss among HIV positive men with osteopenia was modest overall, but about 25% of those taking tenofovir (Viread, also in 4 antiretroviral coformulations) experienced significant loss, according to a recent study. A related meta-analysis found that HIV infection is associated with a modest likelihood of new fractures, with smoking and hepatitis C virus (HCV) coinfection further increasing the risk.

alt